Greenwich LifeSciences, Inc.
NASDAQ:GLSI · NASDAQ Capital Market
+$1.03 today
Vol 0.13M · Avg 0.15M
Filings
Ground the analysis in primary documents
Pair price history with recent company filings so you can connect market moves to the actual disclosures behind the business.
Price History
Dividend-adjusted closing price
Change
+164.45%
Period High
$33.57
Period Low
$7.85
Latest
$23.88
SEC Filings
Recent regulatory filings
No filings found.
Competitors
Peer companies in the same sector
Immix Biopharma, Inc.
NASDAQ:IMMX
$459.70M
Opus Genetics, Inc.
NASDAQ:IRD
$328.84M
Surrozen, Inc.
NASDAQ:SRZN
$174.90M
TuHURA Biosciences, Inc.
NASDAQ:HURA
$147.74M
Agenus Inc.
NASDAQ:AGEN
$137.42M
Seer, Inc.
NASDAQ:SEER
$94.57M
Cognition Therapeutics, Inc.
NASDAQ:CGTX
$89.03M
Oncolytics Biotech Inc.
NASDAQ:ONCY
$80.59M
Tevogen Bio Holdings Inc.
TVGN
$43.84M
Atossa Therapeutics, Inc.
ATOS
$21.18M
What is the latest GLSI filing?
The latest filing shown is 10-Q dated Jun 4, 2026.
How many recent filings does GLSI have?
Intrinsic Alpha currently shows 20 recent filings for GLSI.
Explore More
Continue the stock analysis
Jump to another research area for this company.